Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Clinical Pharmacokinetics|September 27, 2024
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model EnsemblingBram C Agema, Tolra Kocher, Ayşenur B Öztürk, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2016
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancerD de Wit, T C Schneider, D J A R Moes, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2014
Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx®)Marye J Boers-Sonderen, Carla M L van Herpen, Winette T A van der Graaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 TrialsOlivier Mir, Nathan Touati, Michela Lia, et al.
Targeted Oncology|July 21, 2019
Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus ExemestaneAnnelieke E C A B Willemsen, Jolien Tol, Nielka P van Erp, et al.
Molecular Oncology|March 2, 2021
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatmentEmmy Boerrigter, Guillemette E Benoist, Inge M van Oort, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicityNielka P van Erp, Karel Eechoute, Astrid A van der Veldt, et al.
European Urology Oncology|March 14, 2024
A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate CancerEmmy Boerrigter, Joanneke K Overbeek, Guillemette E Benoist, et al.
Clinical Pharmacokinetics|November 16, 2024
A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age GroupsMa Ida Mohmaed Ali, A Laura Nijstad, René J Boosman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 14, 2022
Feasibility of therapeutic drug monitoring of sorafenib in patients with liver or thyroid cancerNiels A D Guchelaar, Ruben A G van Eerden, Stefanie L Groenland, et al.
Pageof 13